How did UTMD's revenue and expenses trend in Q4 2024?

UTMD's revenue and expenses in Q4 2024 showed a business-focused trend, with a strong gross margin of 59.03% and a net income of $2.9 million:

|code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code|
|---|---|---|---|---|---|---|
|UTMD|UTMD.O|Utah Medical Products|20240101-2024|Blood Pressure Monitoring and Accessories|9067000|185|
|UTMD|UTMD.O|Utah Medical Products|20240101-2024|Blood Pressure Monitoring and Accessories|7742000|185|
|UTMD|UTMD.O|Utah Medical Products|20240101-2024|Blood Pressure Monitoring and Accessories|5596000|185|
|UTMD|UTMD.O|Utah Medical Products|20240101-2024|Blood Pressure Monitoring and Accessories|3212000|185|
|UTMD|UTMD.O|Utah Medical Products|20240101-2024|Gynecology/ Electrosurgery/ Urology|5461000|185|
|UTMD|UTMD.O|Utah Medical Products|20240101-2024|Obstetrics|1025000|185|
|UTMD|UTMD.O|Utah Medical Products|20240101-2024|Blood Pressure Monitoring and Accessories|3212000|185|
|UTMD|UTMD.O|Utah Medical Products|20240101-2024|Neonatal|1642000|185|

|code|Ticker|Name|Date|Net Income YoY|Net Income|market_code|
|---|---|---|---|---|---|---|
|UTMD|UTMD.O|Utah Medical Products|2024 Q1|-6.122448979591836|3956000|185|
|UTMD|UTMD.O|Utah Medical Products|2024 Q2|-17.785714285714285|3453000|185|
|UTMD|UTMD.O|Utah Medical Products|2024 Q3|-9.453621346886912|3563000|185|
|UTMD|UTMD.O|Utah Medical Products|2024 Q4|-32.2911805879608|2902000|185|

|code|Ticker|Name|Date|Gross Profit Margin|Gross Profit Margin YoY|market_code|
|---|---|---|---|---|---|---|
|UTMD|UTMD.O|Utah Medical Products|2024 Q1|59.6649|-4.75529900804229|185|
|UTMD|UTMD.O|Utah Medical Products|2024 Q2|59.8804|-2.437259984717226|185|
|UTMD|UTMD.O|Utah Medical Products|2024 Q3|59.2849|-2.076571509742803|185|
|UTMD|UTMD.O|Utah Medical Products|2024 Q4|59.025|-1.3093544185486659|185|

The company's operating expenses were not provided, but the gross margin indicates that UTMD was efficient in managing its costs relative to its revenue. The revenue by segment shows that the company's segments, including Gynecology/Electrosurgery/Urology, Blood Pressure Monitoring and Accessories, Neonatal, Obstetrics, and Labor & Delivery, all contributed to the overall revenue, with the largest segment being Gynecology/Electrosurgery/Urology.